382 related articles for article (PubMed ID: 19845160)
1. Analyses of copy number and mRNA expression level of the alpha-synuclein gene in multiple system atrophy.
Jin H; Ishikawa K; Tsunemi T; Ishiguro T; Amino T; Mizusawa H
J Med Dent Sci; 2008 Mar; 55(1):145-53. PubMed ID: 19845160
[TBL] [Abstract][Full Text] [Related]
2. Alpha-synuclein immunoreactivity and ultrastructural study of glial cytoplasmic inclusions in multiple system atrophy.
Wang Y; Lü C; Ye Z
Chin Med J (Engl); 2002 Oct; 115(10):1491-5. PubMed ID: 12490094
[TBL] [Abstract][Full Text] [Related]
3. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.
Tu PH; Galvin JE; Baba M; Giasson B; Tomita T; Leight S; Nakajo S; Iwatsubo T; Trojanowski JQ; Lee VM
Ann Neurol; 1998 Sep; 44(3):415-22. PubMed ID: 9749615
[TBL] [Abstract][Full Text] [Related]
4. Gene expression changes in postmortem tissue from the rostral pons of multiple system atrophy patients.
Langerveld AJ; Mihalko D; DeLong C; Walburn J; Ide CF
Mov Disord; 2007 Apr; 22(6):766-77. PubMed ID: 17290454
[TBL] [Abstract][Full Text] [Related]
5. Multiple system atrophy (MSA): topographic distribution of the alpha-synuclein-associated pathological changes.
Armstrong RA; Cairns NJ; Lantos PL
Parkinsonism Relat Disord; 2006 Sep; 12(6):356-62. PubMed ID: 16723266
[TBL] [Abstract][Full Text] [Related]
6. Multiplex families with multiple system atrophy.
Hara K; Momose Y; Tokiguchi S; Shimohata M; Terajima K; Onodera O; Kakita A; Yamada M; Takahashi H; Hirasawa M; Mizuno Y; Ogata K; Goto J; Kanazawa I; Nishizawa M; Tsuji S
Arch Neurol; 2007 Apr; 64(4):545-51. PubMed ID: 17420317
[TBL] [Abstract][Full Text] [Related]
7. The role of alpha-synuclein in the pathogenesis of multiple system atrophy.
Wenning GK; Jellinger KA
Acta Neuropathol; 2005 Feb; 109(2):129-40. PubMed ID: 15666181
[TBL] [Abstract][Full Text] [Related]
8. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
9. Expression of the endocytosis regulatory proteins Rab5 and Rabaptin-5 in glial cytoplasmic inclusions from brains with multiple system atrophy.
Nakamura S; Kawamoto Y; Nakano S; Akiguchi I
Clin Neuropathol; 2000; 19(2):51-6. PubMed ID: 10749284
[TBL] [Abstract][Full Text] [Related]
10. Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia.
Miller DW; Johnson JM; Solano SM; Hollingsworth ZR; Standaert DG; Young AB
J Neural Transm (Vienna); 2005 Dec; 112(12):1613-24. PubMed ID: 16284907
[TBL] [Abstract][Full Text] [Related]
11. Alpha-synuclein transgenic mice: relevance to multiple system atrophy.
Fillon G; Kahle PJ
Mov Disord; 2005 Aug; 20 Suppl 12():S64-6. PubMed ID: 16092093
[TBL] [Abstract][Full Text] [Related]
12. Immunoexpression of 14-3-3 proteins in glial cytoplasmic inclusions of multiple system atrophy.
Komori T; Ishizawa K; Arai N; Hirose T; Mizutani T; Oda M
Acta Neuropathol; 2003 Jul; 106(1):66-70. PubMed ID: 12669242
[TBL] [Abstract][Full Text] [Related]
13. Cloning and mapping of ZNF231, a novel brain-specific gene encoding neuronal double zinc finger protein whose expression is enhanced in a neurodegenerative disorder, multiple system atrophy (MSA).
Hashida H; Goto J; Zhao N; Takahashi N; Hirai M; Kanazawa I; Sakaki Y
Genomics; 1998 Nov; 54(1):50-8. PubMed ID: 9806829
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional changes in multiple system atrophy and Parkinson's disease putamen.
Vogt IR; Lees AJ; Evert BO; Klockgether T; Bonin M; Wüllner U
Exp Neurol; 2006 Jun; 199(2):465-78. PubMed ID: 16626704
[TBL] [Abstract][Full Text] [Related]
15. Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy.
Giasson BI; Mabon ME; Duda JE; Montine TJ; Robertson D; Hurtig HI; Lee VM; Trojanowski JQ
Acta Neuropathol; 2003 Sep; 106(3):243-50. PubMed ID: 12811584
[TBL] [Abstract][Full Text] [Related]
16. Alpha-synuclein binding to rab3a in multiple system atrophy.
Dalfó E; Ferrer I
Neurosci Lett; 2005 May 20-27; 380(1-2):170-5. PubMed ID: 15854772
[TBL] [Abstract][Full Text] [Related]
17. alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy.
Sone M; Yoshida M; Hashizume Y; Hishikawa N; Sobue G
Acta Neuropathol; 2005 Jul; 110(1):19-26. PubMed ID: 15895299
[TBL] [Abstract][Full Text] [Related]
18. Role of transcriptional control in multiple system atrophy.
Chen J; Mills JD; Halliday GM; Janitz M
Neurobiol Aging; 2015 Jan; 36(1):394-400. PubMed ID: 25218777
[TBL] [Abstract][Full Text] [Related]
19. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
[TBL] [Abstract][Full Text] [Related]
20. Progressive accumulation of ubiquitin and disappearance of alpha-synuclein epitope in multiple system atrophy-associated glial cytoplasmic inclusions: triple fluorescence study combined with Gallyas-Braak method.
Sakamoto M; Uchihara T; Nakamura A; Mizutani T; Mizusawa H
Acta Neuropathol; 2005 Oct; 110(4):417-25. PubMed ID: 16133540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
